2023-08-07 16:38:24 ET
- AxoGen press release ( NASDAQ: AXGN ): Q2 Non-GAAP EPS of -$0.03 beats by $0.09 .
- Revenue of $38.2M (+10.7% Y/Y) misses by $0.88M .
- Management is maintaining full-year 2023 revenue guidance in the range of $154 million to $159 million, vs. consensus of $157.26M, which represents annual growth of 11% - 15%. The Company anticipates that gross margin will be reduced with the transition to the new processing facility in the third and fourth quarters and that gross margins for the full year 2023 will be approximately 80%.
For further details see:
AxoGen Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $38.2M misses by $0.88M